227 related articles for article (PubMed ID: 4531217)
1. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
Ungerstedt U; Ljungberg T; Steg G
Adv Neurol; 1974; 5():421-6. PubMed ID: 4531217
[No Abstract] [Full Text] [Related]
2. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
[No Abstract] [Full Text] [Related]
3. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
Melamed E
Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
[No Abstract] [Full Text] [Related]
4. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
[TBL] [Abstract][Full Text] [Related]
5. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
6. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
Creese I; Iversen SD
Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
[No Abstract] [Full Text] [Related]
7. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA.
Hefti F; Melamed E; Sahakian BJ; Wurtman RJ
Pharmacol Biochem Behav; 1980 Feb; 12(2):185-8. PubMed ID: 7189592
[TBL] [Abstract][Full Text] [Related]
8. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
Fung YK; Uretsky NJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
[TBL] [Abstract][Full Text] [Related]
9. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model.
Fornaguera J; Schwarting RK; Boix F; Huston JP
Synapse; 1993 Feb; 13(2):179-85. PubMed ID: 7680495
[TBL] [Abstract][Full Text] [Related]
10. Behavioral correlates of dopaminergic supersensitivity.
Iversen SD; Creese I
Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
[No Abstract] [Full Text] [Related]
11. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
12. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
13. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
Chiueh CC; Miyake H; Peng MT
Adv Neurol; 1993; 60():251-8. PubMed ID: 8380519
[No Abstract] [Full Text] [Related]
14. Dopaminergic neuronal sprouting and behavioral recovery in hemi-parkinsonian rats after implantation of amnion cells.
Sheng JG; McShane LM; Plunkett RJ; Cummins AC; Oldfield EH; Kopin IJ; Palmatier MA
Exp Neurol; 1993 Oct; 123(2):192-203. PubMed ID: 8405285
[TBL] [Abstract][Full Text] [Related]
15. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
[TBL] [Abstract][Full Text] [Related]
16. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
Fu Y; Ito M; Fujita Y; Ito M; Ichihara M; Masuda A; Suzuki Y; Maesawa S; Kajita Y; Hirayama M; Ohsawa I; Ohta S; Ohno K
Neurosci Lett; 2009 Apr; 453(2):81-5. PubMed ID: 19356598
[TBL] [Abstract][Full Text] [Related]
17. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
18. [Effects of injecting 6-hydroxydopamine into areas of the nigro-striatal (A9) and mesolimbic (A10) dopaminergic systems on the elaboration of a conditioned feeding reflex in the rat].
Zhukova EM; Spiridonov VK; Loskutova LV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(1):88-94. PubMed ID: 3107237
[TBL] [Abstract][Full Text] [Related]
19. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
20. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
Melamed E; Hefti F; Wurtman RJ
Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
